Microvesicles derived from human umbilical cord mesenchymal stem cells facilitate tubular epithelial cell dedifferentiation and growth via hepatocyte growth factor induction

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Ju, Guan Qun ^a   Cheng, Jun ^d   Zhong, Liang ^a   Wu, Shuai ^e   Zou, Xiang Yu ^b   Zhang, Guang Yuan ^b   Gu, Di ^b   Miao, Shuai ^b   Zhu, Ying Jian ^b   Sun, Jie ^a   Du, Tao ^c  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d Nantong Tongzhou People's Hospital   (China)

^e QINGDAO MUNICIPAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; CONDITIONED MEDIUM; MITOGEN ACTIVATED PROTEIN KINASE KINASE; OXYGEN; PROTEIN KINASE INHIBITOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEDIFFERENTIATION; CELL GROWTH; CELL REGENERATION; CELL STIMULATION; CELL VACUOLE; CONCENTRATION (PARAMETERS); EPITHELIUM CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY TUBULE EPITHELIUM; MALE; MESENCHYMAL STEM CELL; MOLECULAR MECHANICS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; RAT; RNA TRANSPORT; SIGNAL TRANSDUCTION; UMBILICAL CORD BLOOD; ACUTE KIDNEY FAILURE; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL PROLIFERATION; CONDITIONED MEDIUM; CYTOLOGY; DRUG EFFECTS; GENETICS; HUMAN; HYPOXIA; ISCHEMIA; KIDNEY TUBULE; MEMBRANE MICROPARTICLE; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PHARMACOLOGY; SPRAGUE DAWLEY RAT; UMBILICAL CORD;

RATTUS;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; CELL DEDIFFERENTIATION; CELL PROLIFERATION; CELL-DERIVED MICROPARTICLES; CULTURE MEDIA, CONDITIONED; EPITHELIAL CELLS; HEPATOCYTE GROWTH FACTOR; HUMANS; HYPOXIA; ISCHEMIA; KIDNEY TUBULES; MALE; MESENCHYMAL STROMAL CELLS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; OXYGEN; PROTEIN BIOSYNTHESIS; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-MET; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; UMBILICAL CORD;

EID: 84925662989     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121534     Document Type: Article

References (40)

1. Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, et al. Acute kidney injury increases risk of ESRD among elderly. Journal of the American Society of Nephrology: JASN. 2009; 20(1):223-8. doi: 10.1681/ASN.2007080837 PMID: 19020007
2. Venkatachalam MA, Griffin KA, Lan R, Geng H, Saikumar P, Bidani AK. Acute kidney injury: a springboard for progression in chronic kidney disease. American journal of physiology Renal physiology. 2010; 298(5):F1078-94. doi: 10.1152/ajprenal.00017.2010 PMID: 20200097
3. Chawla LS, Amdur RL, Amodeo S, Kimmel PL, Palant CE. The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney international. 2011; 79(12):1361-9. doi: 10.1038/ki. 2011.42 PMID: 21430640
4. Macedo E, Bouchard J, Mehta RL. Renal recovery following acute kidney injury. Current Opinion in Critical Care. 2008; 14(6):660-5. doi: 10.1097/MCC.0b013e328317ee6e PMID: 19005306
5. Bonventre JV. Pathophysiology of AKI: injury and normal and abnormal repair. Contributions to nephrology. 2010; 165:9-17. doi: 10.1159/000313738 PMID: 20427950
6. Chawla LS. Acute kidney injury leading to chronic kidney disease and long-term outcomes of. Contrib Nephrol. 2011; 174:182-90. doi: 10.1159/000329396 PMID: 21921623
7. Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury. The Journal of clinical investigation. 2011; 121(11):4210-21. doi: 10.1172/JCI45161 PMID: 22045571
8. Ishibe S, Cantley LG. Epithelial-mesenchymal-epithelial cycling in kidney repair. Current opinion in nephrology and hypertension. 2008; 17(4):379-85. doi: 10.1097/MNH.0b013e3283046507 PMID: 18660674
9. Humphreys BD, Czerniak S, DiRocco DP, Hasnain W, Cheema R, Bonventre JV. Repair of injured proximal tubule does not involve specialized progenitors. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108(22):9226-31. doi: 10.1073/pnas.1100629108 PMID: 21576461
10. Gobe GC, Johnson DW. Distal tubular epithelial cells of the kidney: Potential support for proximal tubular cell survival after renal injury. The international journal of biochemistry & cell biology. 2007; 39 (9):1551-61.
11. Camussi G, Deregibus MC, Tetta C. Paracrine/endocrine mechanism of stem cells on kidney repair: role of microvesicle-mediated transfer of genetic information. Current opinion in nephrology and hypertension. 2010; 19(1):7-12. doi: 10.1097/MNH.0b013e328332fb6f PMID: 19823086
12. Du T, Zhu YJ. The Regulation of Inflammatory Mediators in Acute Kidney Injury via Exogenous Mesenchymal Stem Cells. Mediators of inflammation. 2014; 2014:261697. doi: 10.1155/2014/261697 PMID: 24839354
13. Gatti S, Bruno S, Deregibus MC, Sordi A, Cantaluppi V, Tetta C, et al. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. 2011; 26(5):1474-83.
14. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, et al. Mesenchymal stem cellderived microvesicles protect against acute tubular injury. Journal of the American Society of Nephrology: JASN. 2009; 20(5):1053-67. doi: 10.1681/ASN.2008070798 PMID: 19389847
15. He J, Wang Y, Sun S, Yu M, Wang C, Pei X, et al. Bone marrow stem cells-derived microvesicles protect against renal injury in the mouse remnant kidney model. Nephrology. 2012; 17(5):493-500. doi: 10.1111/j.1440-1797.2012.01589.x PMID: 22369283
16. Bruno S, Grange C, Collino F, Deregibus MC, Cantaluppi V, Biancone L, et al. Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PloS one. 2012; 7(3):e33115. doi: 10.1371/journal.pone.0033115 PMID: 22431999
17. Kilpinen L, Impola U, Sankkila L, Ritamo I, Aatonen M, Kilpinen S, et al. Extracellular membrane vesicles from umbilical cord blood-derived MSC protect against ischemic acute kidney injury, a feature that is lost after inflammatory conditioning. Journal of extracellular vesicles. 2013;2.
18. Deregibus MC, Cantaluppi V, Calogero R, Lo Iacono M, Tetta C, Biancone L, et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood. 2007; 110(7):2440-8. PMID: 17536014
19. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia. 2006; 20(9):1487-95. PMID: 16791265
20. Ratajczak MZ, Kucia M, Jadczyk T, Greco NJ, Wojakowski W, Tendera M, et al. Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? Leukemia. 2012; 26(6):1166-73. doi: 10.1038/leu.2011.389 PMID: 22182853
21. Camussi G, Deregibus MC, Cantaluppi V. Role of stem-cell-derived microvesicles in the paracrine action of stem cells. Biochemical Society transactions. 2013; 41(1):283-7. doi: 10.1042/BST20120192 PMID: 23356298
22. Du T, Ju G, Wu S, Cheng Z, Cheng J, Zou X, et al. Microvesicles Derived from Human Wharton's Jelly Mesenchymal Stem Cells Promote Human Renal Cancer Cell Growth and Aggressiveness through Induction of Hepatocyte Growth Factor. PloS one. 2014; 9(5):e96836. doi: 10.1371/journal.pone. 0096836 PMID: 24797571
23. Du T, Cheng J, Zhong L, Zhao XF, Zhu J, Zhu YJ, et al. The alleviation of acute and chronic kidney injury by human Wharton's jelly-derived mesenchymal stromal cells triggered by ischemia-reperfusion injury via an endocrine mechanism. Cytotherapy. 2012; 14(10):1215-27. doi: 10.3109/14653249.2012. 711471 PMID: 22920838
24. Wu S, Ju GQ, Du T, Zhu YJ, Liu GH. Microvesicles derived from human umbilical cord Wharton's jelly mesenchymal stem cells attenuate bladder tumor cell growth in vitro and in vivo. PloS one. 2013; 8(4): e61366. doi: 10.1371/journal.pone.0061366 PMID: 23593475
25. Boor P, Ostendorf T, Floege J. Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol. 2010; 6(11):643-56. doi: 10.1038/nrneph.2010.120 PMID: 20838416
26. Grgic I, Duffield JS, Humphreys BD. The origin of interstitial myofibroblasts in chronic kidney disease. Pediatric nephrology. 2012; 27(2):183-93. doi: 10.1007/s00467-011-1772-6 PMID: 21311912
27. Morigi M, Rota C, Montemurro T, Montelatici E, Lo Cicero V, Imberti B, et al. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury. Stem cells. 2010; 28(3):513-22. doi: 10.1002/stem.293 PMID: 20049901
28. Duffield JS, Park KM, Hsiao LL, Kelley VR, Scadden DT, Ichimura T, et al. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. The Journal of clinical investigation. 2005; 115(7):1743-55. PMID: 16007251
29. Bi B, Schmitt R, Israilova M, Nishio H, Cantley LG. Stromal cells protect against acute tubular injury via an endocrine effect. Journal of the American Society of Nephrology: JASN. 2007; 18(9):2486-96. PMID: 17656474
30. Bonventre JV. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. Journal of the American Society of Nephrology: JASN. 2003; 14 Suppl 1:S55-61.
31. Lin F, Moran A, Igarashi P. Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. The Journal of clinical investigation. 2005; 115(7):1756-64. PMID: 16007252
32. Kusaba T, Lalli M, Kramann R, Kobayashi A, Humphreys BD. Differentiated kidney epithelial cells repair injured proximal tubule. Proceedings of the National Academy of Sciences of the United States of America. 2013.
33. Witzgall R, Brown D, Schwarz C, Bonventre JV. Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. The Journal of clinical investigation. 1994; 93(5):2175-88. PMID: 7910173
34. Quesenberry PJ, Dooner MS, Aliotta JM. Stem cell plasticity revisited: the continuum marrow model and phenotypic changes mediated by microvesicles. Experimental hematology. 2010; 38(7):581-92. doi: 10.1016/j.exphem.2010.03.021 PMID: 20382199
35. Quesenberry PJ, Aliotta JM. Cellular phenotype switching and microvesicles. Advanced drug delivery reviews. 2010; 62(12):1141-8. doi: 10.1016/j.addr.2010.06.001 PMID: 20558219
36. Zou X, Zhang G, Cheng Z, Yin D, Du T, Ju G, et al. Microvesicles derived from human Wharton's Jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1. Stem cell research & therapy. 2014; 5(2):40.
37. Rogers SA, Miller SB, Hammerman MR. Enhanced renal IGF-I expression following partial kidney infarction. The American journal of physiology. 1993; 264(6 Pt 2):F963-7. PMID: 8322899
38. Nakamura T, Sakai K, Nakamura T, Matsumoto K. Hepatocyte growth factor twenty years on: Much more than a growth factor. Journal of gastroenterology and hepatology. 2011; 26 Suppl 1:188-202. doi: 10.1111/j.1440-1746.2010.06549.x PMID: 21199531
39. Zhuang S, Yan Y, Han J, Schnellmann RG. p38 kinase-mediated transactivation of the epidermal growth factor receptor is required for dedifferentiation of renal epithelial cells after oxidant injury. The Journal of biological chemistry. 2005; 280(22):21036-42. PMID: 15797859
40. Biancone L, Bruno S, Deregibus MC, Tetta C, Camussi G. Therapeutic potential of mesenchymal stem cell-derived microvesicles. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. 2012; 27(8):3037-42.